Two NIH Technology Transfer experts will be speaking at the Biotechnology Innovation Organization 2025 International Convention taking place in Boston, June 16-19, 2025, with pre-conference sessions taking place June 14-15.

Steve Ferguson, Special Advisor at the NIH Office of Technology Transfer will again be part of the faculty for the BIO Professional Development Course – Become a Biotech or MedTech Entrepreneur. This course covers everything from starting a company to specific market tactics – including Bio Start-Ups: “Doing Business” with the NIH. This course will take place from June 14-15th. Steve will also be a speaker on The Priority Review Voucher Program: Incentivizing Neglected Disease Research and Promoting Biotech Investment and Development for More than a Decade panel. This panel will explore the priority review voucher program, which allows a company with a successful drug approval in a specified area to get a PRV for a different drug application. The FDA aims to review the PRV user’s drug submission in about six months, thus allowing faster entry to market with benefits to patient health, as well as company revenue and competitive advantage. This panel is on June 16th from 4:15-5:15pm.

You can learn more about the professional development course here and learn more about the panel here on BIO’s website.

Michael Salgaller, Unit Supervisor of the Technology Analysis and Marketing Unit of the National Cancer Institute’s Technology Transfer Center will be monitoring a panel on Healthcare AI Opportunities and Headwinds at NIH and the Ecosystem at Large: Fulfilling the Promise or Machine Learning Impaired? This panel will explore how NIH and major stakeholders can best deal with healthcare AI to maximize patient benefits while overcoming difficult hurdles facing this transformative technology.

You can learn more about this panel, Healthcare AI Opportunities and Headwinds at NIH and the Ecosystem at Large: Fulfilling the Promise or Machine Learning Impaired?, and who is participating on BIO’s website.